Viking Therapeutics Inc (VKTX) financials · $3.97B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Viking Therapeutics Inc (VKTX) $3.97B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$393.3M | -$150.9M |
| Net Income | -$359.6M | -$110.0M |
| EPS (Diluted) | -$3.19 | -$1.01 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $715.7M | $908.3M |
| Current Assets | $715.6M | $907.2M |
| Cash & Equivalents | $165.8M | $26.7M |
| Total Liabilities | $76.7M | $28.0M |
| Current Liabilities | $76.7M | $27.4M |
| Shareholders' Equity | $639.1M | $880.3M |
| Retained Earnings | -$847.5M | -$487.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$278.7M | -$87.8M |
| Investing Cash Flow | $341.4M | -$553.4M |
| Financing Cash Flow | $76.4M | $612.5M |
FAQ
What is VKTX P/E and revenue?
Viking Therapeutics Inc (VKTX) $3.97B cap.
What is VKTX revenue?
VKTX income-statement cache has no revenue figure yet.
Is VKTX profitable?
Viking Therapeutics Inc last cached net income is -$359.6M (FY2025).
What are VKTX total assets?
Viking Therapeutics Inc last cached total assets are $715.7M (FY2025).
What is VKTX free cash flow?
No cached cash-flow row for VKTX yet.
Not investment advice. Cached statements, not a live tape.